rb 101 has been researched along with cholecystokinin in 7 studies
| Studies (rb 101) | Trials (rb 101) | Recent Studies (post-2010) (rb 101) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
|---|---|---|---|---|---|
| 57 | 0 | 2 | 10,914 | 466 | 1,074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durieux, C; Fournié-Zaluski, MC; Roques, BP; Ruiz-Gayo, M | 1 |
| Corringer, PJ; Dauge, V; Roques, BP | 1 |
| Noble, F; Roques, BP; Smadja, C | 1 |
| Derrien, M; Maldonado, R; Noble, F; Roques, BP | 1 |
| Derrien, M; Noble, F; Roques, BP | 1 |
| Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Smadja, C; Turcaud, S | 1 |
| Jutkiewicz, EM | 1 |
1 review(s) available for rb 101 and cholecystokinin
| Article | Year |
|---|---|
RB101-mediated protection of endogenous opioids: potential therapeutic utility?
Topics: Aminopeptidases; Animals; Cholecystokinin; Disulfides; Enkephalin, Leucine; Enkephalin, Methionine; Enzyme Inhibitors; Mice; Phenylalanine; Prodrugs; Rats | 2007 |
6 other study(ies) available for rb 101 and cholecystokinin
| Article | Year |
|---|---|
Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Topics: Analgesics; Analgesics, Opioid; Animals; Cholecystokinin; Dipeptides; Disulfides; Dose-Response Relationship, Drug; Enkephalins; Male; Mice; Narcotic Antagonists; Peptide Fragments; Phenylalanine; Prodrugs; Receptors, Cholecystokinin; Receptors, Opioid | 1992 |
CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Disulfides; Enkephalins; Enzyme Inhibitors; Male; Mice; Molecular Sequence Data; Motor Activity; Naltrexone; Narcotic Antagonists; Peptide Fragments; Phenylalanine; Receptors, Cholecystokinin | 1995 |
Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Topics: Amino Acid Sequence; Analgesia; Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Disulfides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Mice; Molecular Sequence Data; Naloxone; Naltrexone; Oligopeptides; Peptide Fragments; Phenylalanine; Receptors, Opioid, delta; Receptors, Opioid, mu; Sincalide | 1994 |
Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
Topics: Analgesics; Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Disulfides; Drug Synergism; Male; Mice; Pain Measurement; Phenylalanine; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Cholecystokinin | 1993 |
Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.
Topics: Amino Acid Sequence; Analgesics; Animals; Cholecystokinin; Disulfides; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Intraventricular; Male; Mice; Molecular Sequence Data; Oligopeptides; Pain; Pain Measurement; Peptide Fragments; Phenylalanine; Sincalide; Spinal Cord | 1993 |
Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
Topics: Analgesics; Animals; Antidepressive Agents; Benzodiazepinones; Cholecystokinin; Disulfides; Enkephalins; Male; Mice; Mice, Inbred Strains; Motor Activity; Peptide Fragments; Phenylalanine; Phenylurea Compounds; Receptors, Cholecystokinin | 1995 |